Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Suarez-Almazor

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
The Journal of Rheumatology|March 3, 2019
Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid ArthritisMaria A Lopez-Olivo, José B Negrón, Richard J Zogala, et al.
Clinical Rheumatology|May 6, 2018
Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiativeGrace H Lo, Sarra M Musa, Jeffrey B Driban, et al.
Arthritis Care & Research|December 1, 2015
Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort StudyKira E Riehm, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Cancer|May 19, 2017
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapyJessica P Hwang, Maria E Suarez-Almazor, Scott B Cantor, et al.
Oncoimmunology|December 21, 2023
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseasesPankti Reid, Sabina Sandigursky, Juhee Song, et al.
The Journal of Rheumatology|June 7, 2007
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritisLaure Gossec, Gillian Hawker, Aileen M Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
The Journal of Rheumatology|May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology TrialsLouise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Annals of the Rheumatic Diseases|April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry studyDeanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer|May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort studyAlice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
The Journal of Rheumatology|March 3, 2019
Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid ArthritisMaria A Lopez-Olivo, José B Negrón, Richard J Zogala, et al.
Clinical Rheumatology|May 6, 2018
Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiativeGrace H Lo, Sarra M Musa, Jeffrey B Driban, et al.
Arthritis Care & Research|December 1, 2015
Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort StudyKira E Riehm, Linda Kwakkenbos, Marie-Eve Carrier, et al.
Cancer|May 19, 2017
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapyJessica P Hwang, Maria E Suarez-Almazor, Scott B Cantor, et al.
Oncoimmunology|December 21, 2023
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseasesPankti Reid, Sabina Sandigursky, Juhee Song, et al.
The Journal of Rheumatology|June 7, 2007
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritisLaure Gossec, Gillian Hawker, Aileen M Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
The Journal of Rheumatology|May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology TrialsLouise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Annals of the Rheumatic Diseases|April 12, 2026
Oral glucocorticoid treatment for checkpoint inhibitor-associated inflammatory arthritis does not affect cancer progression-free survival: a RADIOS Registry studyDeanna P Jannat-Khah, Pankti Reid, Laura C Cappelli, et al.
Journal for Immunotherapy of Cancer|May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort studyAlice Tison, Deanna Jannat-Khah, Laura C Cappelli, et al.
Pageof 25